Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

NCT00869908 · clinicaltrials.gov ↗

COMPLETED

Status

66726

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin aspart
DRUG: insulin detemir
DRUG: biphasic insulin aspart

Sponsor

Novo Nordisk A/S